Central Nervous System Involvement of Rhabdomyosarcoma: A Single Institution Experience

Daniel C. Moreira(St. Jude Children's Research Hospital), Timothy Garrington(Children's Hospital Colorado), Margaret E. Macy(Children's Hospital Colorado), Carrye Cost(University of Colorado Anschutz Medical Campus), Brian Greffe(University of Colorado Denver)
Journal of Pediatric Hematology/Oncology
April 17, 2018
10.1097/mph.0000000000001166
Cited by 20

Related Papers

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
|The Lancet Oncology|2019|341
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
|Journal of Clinical Investigation|2011|197
Mobilization of hobo elements residing within the decapentaplegic gene complex: Suggestion of a new hybrid dysgenesis system in Drosophila melanogaster
|Cell|1987|190
The Mast Cell-restricted Tryptase mMCP-6 Has a Critical Immunoprotective Role in Bacterial Infections
|Journal of Biological Chemistry|2007|179
Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)
|Neuro-Oncology|2022|136